🚀 VC round data is live in beta, check it out!
Navamedic Valuation Multiples
Discover revenue and EBITDA valuation multiples for Navamedic and similar public comparables like Nortech Systems, Rockwell Medical, BPC Instruments, Prolight Diagnostics and more.
Navamedic Overview
About Navamedic
Navamedic ASA is a pharmaceutical company supplying hospitals and pharmacies with pharmaceutical and medical nutrition products. The company generates its revenue from the Nordic countries.
Founded
2002
HQ
Employees
42
Website
Sectors
Financials (LTM)
EV
$65M
Navamedic Financials
Navamedic reported last 12-month revenue of $63M and EBITDA of $6M.
In the same LTM period, Navamedic generated $25M in gross profit, $6M in EBITDA, and had net loss of ($2M).
Revenue (LTM)
Navamedic P&L
In the most recent fiscal year, Navamedic reported revenue of $60M and EBITDA of $5M.
Navamedic expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $63M | XXX | $60M | XXX | XXX | XXX |
| Gross Profit | $25M | XXX | $23M | XXX | XXX | XXX |
| Gross Margin | 40% | XXX | 39% | XXX | XXX | XXX |
| EBITDA | $6M | XXX | $5M | XXX | XXX | XXX |
| EBITDA Margin | 9% | XXX | 8% | XXX | XXX | XXX |
| EBIT Margin | 2% | XXX | 3% | XXX | XXX | XXX |
| Net Profit | ($2M) | XXX | ($2M) | XXX | XXX | XXX |
| Net Margin | (3%) | XXX | (4%) | XXX | XXX | XXX |
| Net Debt | — | — | $16M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Navamedic Stock Performance
Navamedic has current market cap of $49M, and enterprise value of $65M.
Market Cap Evolution
Navamedic's stock price is $2.06.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $65M | $49M | -3.3% | XXX | XXX | XXX | $-0.10 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialNavamedic Valuation Multiples
Navamedic trades at 1.0x EV/Revenue multiple, and 11.3x EV/EBITDA.
EV / Revenue (LTM)
Navamedic Financial Valuation Multiples
As of April 11, 2026, Navamedic has market cap of $49M and EV of $65M.
Equity research analysts estimate Navamedic's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Navamedic has a P/E ratio of (22.9x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $49M | XXX | $49M | XXX | XXX | XXX |
| EV (current) | $65M | XXX | $65M | XXX | XXX | XXX |
| EV/Revenue | 1.0x | XXX | 1.1x | XXX | XXX | XXX |
| EV/EBITDA | 11.3x | XXX | 12.8x | XXX | XXX | XXX |
| EV/EBIT | 41.1x | XXX | 38.0x | XXX | XXX | XXX |
| EV/Gross Profit | 2.6x | XXX | 2.8x | XXX | XXX | XXX |
| P/E | (22.9x) | XXX | (20.1x) | XXX | XXX | XXX |
| EV/FCF | (4.8x) | XXX | 26.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Navamedic Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Navamedic Margins & Growth Rates
Navamedic's revenue in the last 12 month grew by 21%.
Navamedic's revenue per employee in the last FY averaged $1.4M, while opex per employee averaged $0.5M for the same period.
Navamedic's rule of 40 is 33% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Navamedic's rule of X is 69% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Navamedic Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 21% | XXX | 22% | XXX | XXX | XXX |
| EBITDA Margin | 9% | XXX | 8% | XXX | XXX | XXX |
| EBITDA Growth | 44% | XXX | 45% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 33% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 69% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $1.4M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.5M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 8% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 36% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Navamedic Public Comps
See public comps and valuation multiples for other Medical Supplies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Nortech Systems | XXX | XXX | XXX | XXX | XXX | XXX |
| Rockwell Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| BPC Instruments | XXX | XXX | XXX | XXX | XXX | XXX |
| Prolight Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Meditera | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Navamedic M&A Activity
Navamedic acquired XXX companies to date.
Last acquisition by Navamedic was on XXXXXXXX, XXXXX. Navamedic acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Navamedic
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialNavamedic Investment Activity
Navamedic invested in XXX companies to date.
Navamedic made its latest investment on XXXXXXXX, XXXXX. Navamedic invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Navamedic
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Navamedic
| When was Navamedic founded? | Navamedic was founded in 2002. |
| Where is Navamedic headquartered? | Navamedic is headquartered in Norway. |
| How many employees does Navamedic have? | As of today, Navamedic has over 42 employees. |
| Is Navamedic publicly listed? | Yes, Navamedic is a public company listed on Oslo Børs. |
| What is the stock symbol of Navamedic? | Navamedic trades under NAVA ticker. |
| When did Navamedic go public? | Navamedic went public in 2006. |
| Who are competitors of Navamedic? | Navamedic main competitors are Nortech Systems, Rockwell Medical, BPC Instruments, Prolight Diagnostics. |
| What is the current market cap of Navamedic? | Navamedic's current market cap is $49M. |
| What is the current revenue of Navamedic? | Navamedic's last 12 months revenue is $63M. |
| What is the current revenue growth of Navamedic? | Navamedic revenue growth (NTM/LTM) is 21%. |
| What is the current EV/Revenue multiple of Navamedic? | Current revenue multiple of Navamedic is 1.0x. |
| Is Navamedic profitable? | Yes, Navamedic is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Navamedic? | Navamedic's last 12 months EBITDA is $6M. |
| What is Navamedic's EBITDA margin? | Navamedic's last 12 months EBITDA margin is 9%. |
| What is the current EV/EBITDA multiple of Navamedic? | Current EBITDA multiple of Navamedic is 11.3x. |
| What is the current FCF of Navamedic? | Navamedic's last 12 months FCF is ($14M). |
| What is Navamedic's FCF margin? | Navamedic's last 12 months FCF margin is (21%). |
| What is the current EV/FCF multiple of Navamedic? | Current FCF multiple of Navamedic is (4.8x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.